What is the clinical evidence from this study?

Study design: Other. Population: Respiratory syncytial virus (RSV). Intervention: Immunisation program vs. Base model. Primary outcome: Prevented hospitalisations.

What question did this study set out to answer?

The aim is to analyze how increased susceptibility to RSV in children under five years influences transmission dynamics and immunisation outcomes.

March 13, 2026Open Access

The influence of age-dependent susceptibility on RSV transmission dynamics and immunisation population-level impact

Key Result

An infant immunisation program with 80% coverage and 80% efficacy prevented 15.2% of hospitalisations compared to 8.9% in the base model.

Key Points

The aim is to analyze how increased susceptibility to RSV in children under five years influences transmission dynamics and immunisation outcomes.
Analyzed RSV transmission rates in children under 5 years
Examined disease burden within this age group
Assessed the effectiveness of immunisation programmes based on susceptibility
Higher transmission rates of RSV were found in children under 5 years
Increased disease burden correlates with age-related susceptibility
Immunisation programmes may need adjustments to be more effective in this vulnerable group.

Structured PICO

Does pediatric RSV immunisation reduce RSV infections and hospitalisations in the population?

Population

UK population, modeled using Scottish demographic data (2018), virological surveillance data (2017-2023), and hospitalisation rates (2010-2016), categorized into 11 age groups.

Intervention

Modeled pediatric RSV immunisation scenarios (targeting 0-12 months, 0-24 months, or 0-4 years) with varying coverage (60%, 80%) and efficacy (60-80% against infection, 70-90% against hospitalisation).

Comparator

No-immunisation counterfactual scenario and a homogeneous-susceptibility base model.

Outcome

Annual reductions in RSV infections and hospitalisations, and number of individuals needed to immunise (NNI) to prevent one RSV hospitalisation.

Incorporating age-dependent susceptibility, which is higher in children under 5, into transmission models projects a greater population-level impact and efficiency for pediatric RSV immunisation programs.

Main Result

Absolute Event Rate: 15.2% vs 8.9%

Limitations

Age-dependent susceptibility coefficients were estimated using modeling techniques that may not reflect all real-world dynamics.
The analysis did not account for protective effects of maternal vaccination.
Potential variations in contact rates within age groups were not captured.

Abstract

The increased RSV susceptibility in children under 5 years drives higher baseline transmission rates and disease burden in this subgroup, thereby influencing immunisation programme impact and efficiency.

KI fragen

Bookmark

View Full Paper

Cite This Study

Zhao et al. (Wed,) conducted a other in Respiratory syncytial virus (RSV). Immunisation program vs. Base model was evaluated on Prevented hospitalisations. An infant immunisation program with 80% coverage and 80% efficacy prevented 15.2% of hospitalisations compared to 8.9% in the base model.

synapsesocial.com/papers/69b3ac1d02a1e69014ccd7a5 https://doi.org/https://doi.org/10.1186/s12916-026-04776-1

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

KI fragen

Bookmark

View Full Paper